A review of current management of vasculo-Behcet's. Issue 1 (January 2018)

• Record Type: Journal Article
• Authors: Merashli, Mira; Eid, Rozana El; Uthman, Imad
• Is Part Of: Current opinion in rheumatology. Volume 30:Issue 1(2018:Jan.)
• Publication Date: 2018-01
• Subjects: anticoagulation -- Behcet's disease -- thromboembolism -- treatment -- vascular disease; Rheumatology -- Periodicals; Arthritis -- Periodicals; Review Literature -- Periodicals; Rheumatic Diseases -- Periodicals; 616.723
• DOI: 10.1097/BOR.0000000000000458
• Languages: English
• ISSNs: 1040-8711

Abstract

Abstract : Purpose of review: To give an overview of recently published articles about the management of vasculo-Behcet's with particular emphasis on anticoagulation. Recent findings: Biologic agents are emerging as a potential therapeutic option in refractory vasculo-Behcet with a good safety profile. Evidence further shows that following nonpulmonary aneurysm repair, there is a reduced risk of recurrent aneurysmal formation at the operative site in patients treated with immunosuppressants in addition to their surgery, than those undergoing surgical intervention alone. Summary: Behcet disease patients are at risk of developing multiple vascular complications including thrombosis and aneurysms. Treatment should focus on reducing inflammation; and the role of anticoagulation is still debatable.